Industry dynamics

Company News

The Lancet: China's healthcare quality and accessibility rank 60th globally

On August 15th, the National Health and Family Planning Commission held a media communication meeting on the progress of medical quality and service accessibility in recent years. The conference revealed that in May this year, the internationally renowned journal "The Lancet" published a ranking of medical quality and accessibility involving 195 countries and regions. From 1990 to 2015, China's ranking progress ranked third globally. Guo Yanhong, Deputy Director of the Medical Administration Bureau of the National Health and Family Planning Commission, introduced that research shows that from 1990 to 2015, China was one of the countries with the greatest progress in medical quality, and the HAQ (Medical Quality and Accessibility) index was determined by

2021

04-21

Liu Yandong: Deepening the Reform of Health and Health Services, Creating a New Situation in Building a Healthy China

Health is the foundation of people's happiness and social development, and it is the common pursuit of a better life among the people of the whole country. Subsequently, the Central Committee of the Communist Party of China and the State Council issued and implemented the "Healthy China 2030" Plan Outline (hereinafter referred to as the "Plan Outline"), outlining a beautiful blueprint for building a healthy China

2021

04-21

The National Health and Family Planning Commission's Ten Key Tasks for "Regulating and Releasing Services" have been released!

On August 14th, the "Notice of the National Health and Family Planning Commission on Deepening the Reform of" Decentralization, Management, and Service "to Stimulate Investment Vitality in the Medical Field" (hereinafter referred to as the "Notice") was officially released. The "Notice" clearly stated that the approval for the establishment of clinics in elderly care institutions will be cancelled, and a filing system will be implemented. At the same time, the "Notice" also deployed the next key work in China's health and family planning field: the ten key tasks in the national medical and health field have been determined Cancel the approval for the establishment of clinics in elderly care institutions and implement a filing system. Health and family planning departments at all levels should supervise the implementation of relevant policies and strengthen supervision during and after the event to promote the development of the health and elderly care service industry.

2021

04-21

Experience sharing in the intelligent construction of the First Affiliated Hospital of Zhejiang University

The continuous deepening of the new medical reform has made it an objective need to promote the construction process of smart hospitals. As the first hospital affiliated with Zhejiang University (hereinafter referred to as "Zhejiang University First Hospital") in the world to pass the sixth edition JCI evaluation with high scores and receive a donation of 560 million from Jack Ma, it continuously promotes the implementation and application of "medical+internet" in the entire medical service process through innovative models. The informatization construction of Zhejiang University First Hospital can be traced back to 1987. It has been 30 years since the start of informatization construction to the current construction of "Zhejiang First Smart Hospital". 2017 China Medical Equipment Association Digital Medical Branch Annual Meeting

2021

04-21

Multiple experts discuss the blueprint for the development of medical and health services in Inner Mongolia in the new era

On July 29, 2017, the Inner Mongolia Hospital Association Hospital Information Statistics Professional Committee Annual Meeting and Hospital Information Technology Application Conference were successfully held at Huaxi Business Hotel in Xilinhot, Inner Mongolia. This meeting is hosted by Inner Mongolia Hospital Association and co organized by Xilingol League Hospital and HC3i China Digital Medical Network. Nasong Bayar, the director of Xilingol League Hospital in Inner Mongolia, first delivered a welcome speech.

2021

04-21

Our company is honored to become a licensed medical dressing production base of Jiangsu Huihong Pharmaceutical.

On December 11, 2016, on a sunny day, our company lit up lanterns and decorated them to welcome all members of the leadership team and the medical equipment team of Jiangsu Huihong International Group Medical and Health Products Import and Export Co., Ltd., and held a listing ceremony for the medical dressing production base. All employees of our company, leaders of Anji County, and relevant leaders of the development zone jointly attended the listing ceremony.

2021

04-21

HER2 gene abnormalities are also a common treatment entry point in colorectal cancer

There are several key gene loci that require additional attention in the treatment of colorectal cancer (CRC). In addition to the RAS gene that affects the efficacy of drugs such as cetuximab and MSI/PD-L1 that affects immune therapy related indicators, HER2 gene abnormalities are also a common treatment entry point in colorectal cancer.

2021

12-22

Detailed explanation of common genetic variation types

At the cellular level, a gene is equivalent to a point on a chromosome, called a locus. At the molecular level, a site can also be divided into many basic units, called seats. A locus generally refers to a nucleotide pair, and sometimes a mutation may occur when one of the bases changes.

2021

12-01

Detailed explanation of the relationship between oncogene and human genes

The cure rate of late stage tumors is less than 20%, and if discovered in the first stage, the cure rate can reach as high as 95%. The reason why the mortality rate of cancer remains high is because it is found to be very difficult to treat in the middle and late stages. With the development of medicine, people have found the relationship between genes and tumors. Through gene examination, tumor indicators can be found, which can greatly improve the Lebensraum of patients.

2021

11-23

Accurate detection is essential for accurate medication use, starting from MET for lung cancer

Lung cancer is a malignant tumor that poses a serious threat to human health in the world today, and advances in molecular biology have greatly changed the treatment pattern of advanced NSCLC. The targeted treatment of lung cancer cannot be separated from molecular detection of lung cancer, which involves various aspects, and any factor may affect the accuracy of molecular detection results. In order to standardize the molecular detection of lung cancer, AZ collaborated with relevant domestic experts to comprehensively elaborate on the sample requirements, testing platform, testing treatment and standards, and testing concepts for molecular detection of lung cancer.

2021

11-08

< 1 >